Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center at Jefferson ...
Sep 1, 2011
0
0
(HealthDay)—For adult patients with Crohn's disease, adalimumab and infliximab + azathioprine are most effective for induction and maintenance of remission, according to a meta-analysis published in the February issue of ...
Jan 28, 2015
0
6
Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study ...
Jul 31, 2013
0
1
Cancer patients who have higher levels of vitamin D when they are diagnosed tend to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to a new study published in ...
Apr 29, 2014
0
2
Avacopan was better than prednisone in reducing respiratory as well as ear, nose and throat (ENT) involvement in ANCA-associated vasculitis patients participating in the phase 3 ADVOCATE trial, and enabled reduced glucocorticoid ...
May 18, 2022
0
9
(Medical Xpress) -- Chemotherapy kills tumor cells, but it also wreaks havoc on the rest of the body. A team of researchers led by Igor Roninson of the South Carolina College of Pharmacy just reported the discovery of a new ...
Aug 7, 2012
0
0
In this issue of the Journal of Clinical Investigation, researchers led by Scott Pruitt at Duke University and Merck Research Laboratories report on a human clinical trial in which modified dendritic cells, a component of ...
Jun 24, 2013
0
0
Researchers from the Germans Trias i Pujol Research Institute (IGTP) have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes in collaboration with experts in ...
Nov 14, 2023
0
5
Using fractionated doses of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients aged 50-70 years with acute myeloid leukaemia (AML) and substantially improves their outcomes. ...
Apr 4, 2012
0
0
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, has found that rheumatoid arthritis (RA) patients in sustained remission who stopped TNF inhibitors (TNFi) had significantly ...
Nov 10, 2023
0
1
